Large US study confirms most mRNA COVID-19 vaccine side effects are mild and temporary

Study finds providing telehealth technology access may expand reach and benefits
7 March 2022
As virus cases go from 1 to 24,000, New Zealand changes tack
8 March 2022

Large US study confirms most mRNA COVID-19 vaccine side effects are mild and temporary

A review of adverse events following vaccination against COVID-19 with mRNA vaccines in the U.S. confirms that most side effects were mild and decreased substantially after one day. The new study, published in The Lancet Infectious Diseases journal, suggests that for more than 298 million vaccine doses administered between December 2020 and June 2021, 92% (313,499/340,522) of reported adverse events were not serious, and less than 1% of v-safe participants reported seeking any medical care following vaccination.

Comments are closed.